| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Metabolism and Endocrinology (A.Y.G., M.C., C.F.H.V.S., J.C.H., D.G.P.), Vrije Universiteit Brussel, Belgium; and Division of Biopharmaceutics (Th.J.C.V.B.), Center for Bio-Pharmaceutical Sciences, Sylvius Laboratory, University of Leiden, The Netherlands
Address all correspondence and requests for reprints to: A. Y. Grupping, Department of Metabolism and Endocrinology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussel, Belgium. E-mail: agrup{at}mebo.vub.ac.be
Abnormalities in lipoprotein metabolism are common in diabetes. It is unknown whether variations in form or concentration of lipoproteins influence the function of pancreatic ß cells. This study investigates whether low density lipoproteins (LDL) exhibit specific interactions with islet ß cells. Radioactively labeled LDL (125I-LDL) and fluorescently labeled LDL (DiI-LDL) were used as tracers. Rat islet cells express high affinity LDL binding sites (Kd = 9 nM), which are also recognized by very low density lipoproteins and which are down-regulated by LDL. Binding of LDL appears restricted to the ß cells, as it was not detected on islet endocrine non-ß cells. At 37 C, LDL is taken up and lysosomally degraded by islet ß cells but not by islet non-ß cells. Human islet cells were also found to present LDL binding, uptake, and degradation. Compared with rat islet cells, human islet cells exhibit 10-fold less binding sites (2.107 vs. 2.108 per 103 cells) with a 2-fold lower Kd value (5 nM) and an equal sensitivity to LDL-induced down-regulation. In conclusion, human and rat islet ß cells express LDL receptors that can internalize the lipoprotein. This pathway should be examined for its potential role in (dys)regulating pancreatic ß cell functions.
This article has been cited by other articles:
![]() |
J. B. Flowers, M. E. Rabaglia, K. L. Schueler, M. T. Flowers, H. Lan, M. P. Keller, J. M. Ntambi, and A. D. Attie Loss of Stearoyl-CoA Desaturase-1 Improves Insulin Sensitivity in Lean Mice but Worsens Diabetes in Leptin-Deficient Obese Mice Diabetes, May 1, 2007; 56(5): 1228 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Carabeo, D. J. Mead, and T. Hackstadt Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion PNAS, May 27, 2003; 100(11): 6771 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Roehrich, V. Mooser, V. Lenain, J. Herz, J. Nimpf, S. Azhar, M. Bideau, A. Capponi, P. Nicod, J.-A. Haefliger, et al. Insulin-secreting beta -Cell Dysfunction Induced by Human Lipoproteins J. Biol. Chem., May 9, 2003; 278(20): 18368 - 18375. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cnop, J. C. Hannaert, A. Y. Grupping, and D. G. Pipeleers Low Density Lipoprotein Can Cause Death of Islet {beta}-Cells by Its Cellular Uptake and Oxidative Modification Endocrinology, September 1, 2002; 143(9): 3449 - 3453. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cnop, A. Grupping, A. Hoorens, L. Bouwens, M. Pipeleers-Marichal, and D. Pipeleers Endocytosis of Low-Density Lipoprotein by Human Pancreatic {beta} Cells and Uptake in Lipid-Storing Vesicles, Which Increase with Age Am. J. Pathol., January 1, 2000; 156(1): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |